Table 2.
Primers | Sequence |
---|---|
Cycline E1 F | 5′- GACAGCTAGCGCGGTGTAG-3’ |
Cycline E1 R | 5′-TTGGAACTCAGACCCGAAGC-3’ |
Cdk2 F | 5′-CTTTGCCGAAATGGTGACCC-3’ |
Cdk2 R | 5′- CCCAGAGTCCGAAAGATCCG-3’ |
NPAT F | 5′- CCTTTTAAGGGCCACCACCTC-3’ |
NPAT R | 5′- AAGGGTAAAGACGCGAGGAC-3’ |
SLBP F | 5′- AGCTCTCCTTCAAACCACCG-3’ |
SLBP R | 5′- ATGGCCTTCAGGCGTTGTAA-3’ |
H2A F | 5′- AAGCTCGTGCAAAAGCGAAG-3’ |
H2A R | 5′- CCTAATGAGGTTGGGGGTGG-3’ |
H3 F | 5′- CGTTGGAGGAGCTTCGTCTT-3’ |
H3 R | 5′- TTGGTTCGGGCCATCTTCTC-3’ |
H4 F | 5′-GCAAGGTCTTGCGGGATAAC-3’ |
H4 R | 5′- GCTCAGTGTAGGTGACTGCG-3’ |
F forward primer, R reverse primer, cdk2 cyclin dependent kinase 2, NPAT nuclear protein ataxia-telangiectasia; SLBP: stem-loop binding protein